RAPT Therapeutics Stock (NASDAQ: RAPT) stock price, news, charts, stock research, profile.
You can purchase shares of RAPT Therapeutics (NASDAQ:RAPT) through any online brokerage.
Other companies in RAPT Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Fortress Biotech (NASDAQ:FBIO), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and FibroGen (NASDAQ:FGEN).
RAPT Therapeutics has a consensus price target of $23.09.
The stock price for RAPT Therapeutics (NASDAQ: RAPT) is $1.7199 last updated January 7, 2025 at 8:08 AM EST.
There are no upcoming dividends for RAPT Therapeutics.
RAPT Therapeutics’s Q4 earnings are confirmed for Thursday, March 6, 2025.
There is no upcoming split for RAPT Therapeutics.
RAPT Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.